CJC-1295 + Ipamorelin — the most-cited growth-hormone secretagogue research stack in US laboratory literature.
CJC-1295 and ipamorelin are commonly studied together because they engage complementary growth-hormone secretagogue pathways. CJC-1295 is a GHRH analog; ipamorelin is a selective GHSR agonist.
Why the combination is studied together
- GHRH-axis stimulation (CJC-1295)
- Ghrelin-axis stimulation (ipamorelin) without prolactin or cortisol elevation in published rodent literature
- Independent mechanisms allow co-administration in pharmacokinetic studies
Research use only. PeptAra supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
